News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Deals
Reliant Pharmaceuticals, Inc. Pulls IPO Due To Conditions
November 17, 2005
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
WASHINGTON, Nov 17 (Reuters) - Reliant Pharmaceuticals Inc., which markets branded cardiovascular pharmaceutical products, on Thursday withdrew its planned $300 million initial public offering due to unfavorable market conditions.
Twitter
LinkedIn
Facebook
Email
Print
IPO
MORE ON THIS TOPIC
Manufacturing
Samsung Biologics inks $262M manufacturing deal with European pharma company
September 11, 2026
·
2 min read
·
Nick Paul Taylor
IPO
2026 IPO stock tracker: How newly public biotechs are performing
September 9, 2026
·
1 min read
·
Gabrielle Masson
IPO
Steady stream of crossover rounds stock biotech’s IPO pipeline
September 9, 2026
·
7 min read
·
Annalee Armstrong
Deals
Biotech is back, with H1 progress smoothing glide path through end of year: Truist
September 4, 2026
·
3 min read
·
Annalee Armstrong
